Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 441

1.

Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?

Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien JB, Kamara L, Landry S.

Vaccine. 2008 Dec 2;26(51):6706-16. doi: 10.1016/j.vaccine.2008.10.015. Review.

PMID:
18952134
[PubMed - indexed for MEDLINE]
2.

Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.

Kamara L, Milstien JB, Patyna M, Lydon P, Levin A, Brenzel L.

Vaccine. 2008 Dec 2;26(51):6717-26. doi: 10.1016/j.vaccine.2008.10.014. Review.

PMID:
18955100
[PubMed - indexed for MEDLINE]
3.

The GAVI Financing Task Force: one model of partner collaboration.

Milstien JB, Kamara L, Lydon P, Mitchell V, Landry S.

Vaccine. 2008 Dec 2;26(51):6699-705.

PMID:
19306508
[PubMed - indexed for MEDLINE]
4.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
[PubMed - indexed for MEDLINE]
5.

Financial challenges of immunization: a look at GAVI.

Kaddar M, Lydon P, Levine R.

Bull World Health Organ. 2004 Sep;82(9):697-702.

PMID:
15628208
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.

Martin JF, Marshall J.

Vaccine. 2003 Jan 30;21(7-8):587-92.

PMID:
12531322
[PubMed - indexed for MEDLINE]
8.

The introduction of new vaccines into developing countries II. Vaccine financing.

Mahoney RT, Ramachandran S, Xu Z.

Vaccine. 2000 Jun 1;18(24):2625-35. Review.

PMID:
10781848
[PubMed - indexed for MEDLINE]
9.

GAVI and the Vaccine Fund--a boon for immunization in the developing world.

Balaji KA.

Indian J Public Health. 2004 Apr-Jun;48(2):45-8.

PMID:
15709583
[PubMed - indexed for MEDLINE]
10.

Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines.

Glatman-Freedman A, Cohen ML, Nichols KA, Porges RF, Saludes IR, Steffens K, Rodwin VG, Britt DW.

PLoS One. 2010 Nov 2;5(11):e13802. doi: 10.1371/journal.pone.0013802.

PMID:
21072192
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience.

Hajjeh R.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2827-32. doi: 10.1098/rstb.2011.0046. Review.

PMID:
21893547
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).

Le Gargasson JB, Breugelmans JG, Mibulumukini B, Da Silva A, Colombini A.

Vaccine. 2013 Apr 8;31(15):1886-91. doi: 10.1016/j.vaccine.2013.02.024. Epub 2013 Feb 24.

PMID:
23462529
[PubMed - indexed for MEDLINE]
13.

Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature.

Griffiths UK, Miners A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):333-46. doi: 10.1586/erp.09.38. Review.

PMID:
19670994
[PubMed - indexed for MEDLINE]
14.

GAVI, the first steps: lessons for the Global Fund.

Brugha R, Starling M, Walt G.

Lancet. 2002 Feb 2;359(9304):435-8.

PMID:
11844535
[PubMed - indexed for MEDLINE]
15.

The costs of scaling up vaccination in the world's poorest countries.

Bishai D, McQuestion M, Chaudhry R, Wigton A.

Health Aff (Millwood). 2006 Mar-Apr;25(2):348-56.

PMID:
16522576
[PubMed - indexed for MEDLINE]
Free Article
16.

Global use of Haemophilus influenzae type b conjugate vaccine.

Ojo LR, O'Loughlin RE, Cohen AL, Loo JD, Edmond KM, Shetty SS, Bear AP, Privor-Dumm L, Griffiths UK, Hajjeh R.

Vaccine. 2010 Oct 8;28(43):7117-22. doi: 10.1016/j.vaccine.2010.07.074. Epub 2010 Aug 4.

PMID:
20691265
[PubMed - indexed for MEDLINE]
18.

Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):148-51.

PMID:
18272957
[PubMed - indexed for MEDLINE]
Free Article
19.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.

Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

PMID:
20659515
[PubMed - indexed for MEDLINE]
20.

Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia.

Grundy J.

Health Policy Plan. 2010 May;25(3):186-96. doi: 10.1093/heapol/czp047. Epub 2009 Nov 19.

PMID:
19926659
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk